Invacare Beheer

Beheer criteriumcontroles 3/4

De CEO Invacare is Geoff Purtill, benoemd in Aug2022, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 918.28K, bestaande uit 53% salaris en 47% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.073% van de aandelen van het bedrijf, ter waarde $ 375.22. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.8 jaar en 3.1 jaar.

Belangrijke informatie

Geoff Purtill

Algemeen directeur

US$918.3k

Totale compensatie

Percentage CEO-salaris	53.0%
Dienstverband CEO	less than a year
Eigendom CEO	0.07%
Management gemiddelde ambtstermijn	2.8yrs
Gemiddelde ambtstermijn bestuur	3.1yrs

Recente managementupdates

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

May 14

Invacare EPS misses by $0.02, misses on revenue

May 05

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

May 03

Invacare Corporation's (NYSE:IVC) Path To Profitability

Mar 03

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Feb 05

What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Jan 10

Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Dec 14

Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Nov 23

Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation

Oct 30

Analyse CEO-vergoeding

Hoe is Geoff Purtill's beloning veranderd ten opzichte van Invacare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Dec 31 2022	US$918k	US$486k	-US$101m

Compensatie versus markt: De totale vergoeding ($USD 918.28K ) Geoff } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 649.07K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Geoff te vergelijken met de prestaties van het bedrijf.

CEO

Geoff Purtill (52 yo)

less than a year

Tenure

US$918,284

Compensatie

Mr. Geoffrey P. Purtill, also known as Geoff, serves as President and Chief Executive Officer at Invacare Corporation since November 2022 and serves as its Director since December 09, 2022 and served as it...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Geoffrey Purtill	CEO, President & Director	less than a year	US$918.28k	0.073% $ 375.2
Kathleen Leneghan	Senior VP & CFO	5.5yrs	US$777.11k	0.34% $ 1.7k
Anthony LaPlaca	Senior VP	14.3yrs	US$561.04k	0.23% $ 1.2k
Lois Lee	Director of Treasury & Investor Relations	no data	geen gegevens	geen gegevens
Cintia Ferreira	Chief Human Resources Officer	less than a year	geen gegevens	geen gegevens
Joost Beltman	Senior Vice President of Commercial Operations & Central	2.8yrs	US$800.41k	0.053% $ 270.5

2.8yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van IVCR.Q wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Geoffrey Purtill	CEO, President & Director	less than a year	US$918.28k	0.073% $ 375.2
Aron Schwartz	Independent Director	1.2yrs	US$118.63k	geen gegevens
Edward Crawford	Independent Director	less than a year	US$31.11k	geen gegevens
Michael Merriman	Independent Non-Executive Chairman	9yrs	US$170.95k	geen gegevens
Clifford Nastas	Lead Independent Director	8yrs	US$162.46k	0.23% $ 1.2k
Steven Rosen	Independent Director	less than a year	US$31.11k	geen gegevens
Marc Gibeley	Independent Director	7.5yrs	US$165.67k	0.18% $ 944.9
Petra Danielsohn-Weil	Independent Director	5yrs	US$144.92k	0.14% $ 708.2

3.1yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van IVCR.Q wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Invacare Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Invacare Holdings Corporation Announces Executive Changes

Invacare Corporation Appoints Geoffrey P. Purtill as President

Invacare Corporation Announces Executive Changes

Invacare Corporation Announces Board and Committee Appointments

Invacare Corporation, Annual General Meeting, May 19, 2022

Independent Director recently sold US$59k worth of stock

Recent updates

Invacare Corporation announced delayed 10-Q filing

Silverback Asset Management Engages with Invacare Corporation

Invacare Corporation announced delayed annual 10-K filing

Invacare Corporation announced delayed 10-Q filing

Invacare Corporation Enters Settlement Agreement with Sunrise Medical (Us) Llc and Sunrise Medical Gmbh

Invacare Holdings Corporation Announces Executive Changes

Invacare Corporation(OTCPK:IVCR.Q) dropped from S&P TMI Index

NYSE to Suspend Trading Immediately in Invacare Corporation and Commence Delisting Proceedings

Invacare Corporation Filed for Bankruptcy

Invacare falls on bankruptcy filing

Invacare Corporation Filed for Bankruptcy

Invacare announces additional draw of $5.5M term loans

Invacare Corporation Appoints Geoffrey P. Purtill as President

Price target decreased to US$1.65

Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare GAAP EPS of -$0.92, revenue of $170.4M

Invacare Corporation to Report Q3, 2022 Results on Nov 07, 2022

Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

Invacare receives non-compliance letter from NYSE

Invacare Corporation Announces Executive Changes

Invacare names Geoffrey Purtill as interim president and executive chief

Invacare Corporation Announces Board and Committee Appointments

Invacare adds two new directors after deal with largest investor Azurite

Consensus EPS estimates fall by 77%

Price target decreased to US$4.27

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q2, 2022 Results on Aug 08, 2022

Invacare Corporation(NYSE:IVC) dropped from Russell 2000 Value Index

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Consensus EPS estimates fall by 43%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Invacare Corporation Reaffirms Revenue Guidance for the Full Year 2022

Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Price target decreased to US$6.25

Invacare Corporation to Report Q1, 2022 Results on May 09, 2022

Invacare Corporation, Annual General Meeting, May 19, 2022

Consensus EPS estimates fall by 148%

Price target decreased to US$7.00

Full year 2021 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q4, 2021 Results on Mar 08, 2022

Invacare Corporation Introduces Its Next Generation E-Fix Eco Power Assist Device to Transform the Manual Wheelchair

Invacare Corporation Introduces New, Narrow Version of Invacare® AVIVA® STORM RX™ Rear Wheel Drive Power Wheelchair

Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Invacare Announces New Features in LiNX® 3 Electronics

Senior VP & GM of EMEA Ralf Ledda has left the company

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.65 loss per share (vs US$0.21 loss in 3Q 2020)

Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

Price target decreased to US$11.33

Invacare Corporation Provides Sales Guidance for the Third Quarter and Full Year 2021

Independent Director Baiju Shah has left the company

Independent Director recently sold US$59k worth of stock

Consensus forecasts updated

When Should You Buy Invacare Corporation (NYSE:IVC)?

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.48 loss in 2Q 2020)

Invacare Corporation Introduces the Invacare® AVIVA STORM RX, a Next Generation Rear Wheel Drive Power Wheelchair

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

Consensus EPS estimates fall to -US$0.56

First quarter 2021 earnings released: US$0.41 loss per share (vs US$0.022 profit in 1Q 2020)

Invacare Corporation Reaffirms Earnings Guidance for the Full Year 2021

Invacare EPS misses by $0.02, misses on revenue

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations, earnings disappoint

Invacare Corporation's (NYSE:IVC) Path To Profitability

Invacare Corporation and Its Subsidiary, Alber Usa, LLC Introduces the Next Generation Alber E-Motion® Power Assist Device